by Scott Ford | Dec 30, 2025 | Cancer, Cancer Biopsy, Cancer Testing, Cancer Treatments, Clinical Trials, Cryopreservation
The $900 Cancer Game Changer How Cryopreservation Could Save Your Life When you hear the word “biopsy,” your mind immediately jumps to results. Will it be cancer? What stage? What’s the treatment plan? But there’s a critical question most...
by Scott Ford | Dec 29, 2025 | Cancer, Cancer Biopsy, Cancer Testing, Cancer Treatments, Clinical Trials, Cryopreservation, Cryopreserved Tissue
AI-Powered Cancer Care Why Forward-Thinking Patients Are Demanding Precision Testing Before Treatment The statistics are sobering: approximately 50% of first-time cancer treatments fail. After months of grueling chemotherapy, radiation, or targeted therapy, half of...
by Scott Ford | Dec 22, 2025 | Cancer, Cancer Testing, Cancer Treatments, Clinical Trials, tumor tissue
The Sad Truth About “Standard” Cancer Treatment Why Testing Before Treatment can change everything If you or someone you love has just heard the word cancer, the next question usually comes fast: “What do we do next?” Most patients assume the answer will be precise....
by Scott Ford | Dec 15, 2025 | Cancer, Cancer Biopsy, Cancer Testing, Cancer Treatments, Clinical Trials, Cryopreservation, Cryopreserve Tissue
Three Advanced Cancer Tests Most Patients Never Hear About—and Why Tissue Preservation Comes First In the United States, cancer is not a rare event—it’s a common life chapter for far too many families. Depending on how you count and which population statistics you...
by Scott Ford | Dec 11, 2025 | Cancer, Cancer Biopsy, Cancer Testing, Cancer Treatments, Clinical Trials, Cryopreservation
Cancer care is in the middle of a quiet revolution—and the smartest money in healthcare has noticed. In the last few weeks alone: Abbott announced a ~$21–23 billion acquisition of Exact Sciences, the company behind Cologuard and major precision-oncology assays like...
Recent Comments